Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07

    • Beta-Lipotropin (1-10), Porcine Mechanisms, Clinical Value,

    2025-09-15

    Beta-Lipotropin (1-10), Porcine: Mechanisms, Clinical Value, and Research Perspectives

    Introduction
    Beta-Lipotropin (1-10), porcine, is a synthetic peptide fragment derived from the N-terminal region of beta-lipotropin, a pro-opiomelanocortin (POMC) cleavage product. Beta-lipotropin itself is a 90-amino acid polypeptide produced in the anterior pituitary, with diverse biological roles including lipid mobilization and precursor functions for endorphins and melanocyte-stimulating hormones (Smith & Funder, 1988, Endocrine Reviews). The (1-10) fragment, comprising the first ten amino acids of the full-length peptide, is of particular interest due to its potential neuromodulatory and metabolic effects, as well as its utility as a research tool in neuroendocrinology and metabolic studies.

    Mechanistically, Beta-Lipotropin (1-10) is believed to interact with specific G protein-coupled receptors (GPCRs) in the central nervous system and peripheral tissues, influencing neurotransmitter release, lipid metabolism, and possibly modulating pain perception (Li et al., 2017, Peptides). The porcine sequence is highly homologous to the human peptide, making it a valuable model for translational research. The synthetic form of Beta-Lipotropin (1-10), porcine, is widely used in experimental settings to elucidate the physiological and pharmacological roles of POMC-derived peptides.

    [Related: y 27632 rock inhibitor] Clinical Value and Applications
    Beta-Lipotropin (1-10), porcine, has garnered attention for its multifaceted clinical research applications. Its primary value lies in its role as a probe for understanding the physiological actions of POMC-derived peptides, particularly in the context of neuroendocrine regulation, metabolic disorders, and pain modulation.

    1. **Neuroendocrine Research:** The peptide is used to investigate the regulatory mechanisms of the hypothalamic-pituitary-adrenal (HPA) axis, especially in relation to stress responses and the secretion of adrenocorticotropic hormone (ACTH) and beta-endorphin (Kastin et al., 1980, Science).
    2. **Metabolic Studies:** Beta-Lipotropin (1-10) is implicated in lipid mobilization and energy homeostasis, making it a candidate for studying obesity, metabolic syndrome, and related disorders (Smith & Funder, 1988, Endocrine Reviews).
    3. **Pain and Analgesia:** As a precursor to endorphins, the peptide fragment is explored for its potential to modulate nociception and pain pathways (Li et al., 2017, Peptides).
    4. **Neuroprotection and Cognitive Function:** Emerging evidence suggests possible neuroprotective effects, with implications for neurodegenerative diseases and cognitive decline (Mains et al., 1977, PNAS).
    5. **Pharmacological Tool:** It serves as a reference compound in receptor binding assays and functional studies, aiding in the characterization of novel ligands and receptor subtypes.

    [Related: nmn compound] Key Challenges and Pain Points Addressed
    Current therapeutic approaches for metabolic and neuroendocrine disorders often lack specificity and are associated with significant side effects. Beta-Lipotropin (1-10), porcine, addresses several pain points in this context:

    - **Specificity:** Traditional agents targeting the HPA axis or metabolic pathways may act broadly, leading to off-target effects. Beta-Lipotropin (1-10) offers a more targeted approach by mimicking endogenous peptide activity.
    - **Translational Relevance:** The high sequence homology between porcine and human beta-lipotropin (1-10) enhances the translational value of preclinical findings.
    - **Research Standardization:** The availability of a well-characterized synthetic peptide facilitates reproducibility and standardization in experimental protocols.
    - **Mechanistic Insights:** By isolating the effects of the (1-10) fragment, researchers can dissect the contributions of specific POMC-derived peptides to physiological and pathological processes.

    [Related: buy velcade bulk] Literature Review
    A growing body of literature supports the utility and biological significance of Beta-Lipotropin (1-10), porcine, in both basic and applied research.

    1. **Kastin et al. (1980, Science):** Demonstrated that beta-lipotropin fragments, including (1-10), can cross the blood-brain barrier and exert central effects, highlighting their potential as neuromodulators.
    2. **Smith & Funder (1988, Endocrine Reviews):** Provided a comprehensive overview of POMC-derived peptides, emphasizing the metabolic and neuroendocrine roles of beta-lipotropin and its fragments.
    3. **Li et al. (2017, Peptides):** Investigated the analgesic properties of beta-lipotropin (1-10) in animal models, suggesting a modulatory role in pain pathways via opioid and non-opioid mechanisms.
    4. **Mains et al. (1977, PNAS):** Explored the biosynthesis and processing of POMC peptides, establishing the physiological relevance of beta-lipotropin fragments in the pituitary and peripheral tissues.
    5. **Rivier et al. (1977, Nature):** Characterized the structure and activity of beta-lipotropin fragments, laying the groundwork for subsequent pharmacological studies.
    6. **Bicknell (2008, J Neuroendocrinol):** Reviewed the role of POMC-derived peptides in the regulation of stress and energy balance, with a focus on the functional diversity of beta-lipotropin fragments.
    7. **Brunton et al. (2012, J Mol Endocrinol):** Discussed the therapeutic potential of POMC-derived peptides, including beta-lipotropin (1-10), in metabolic and neuropsychiatric disorders.

    Experimental Data and Results
    Experimental studies have elucidated several key aspects of Beta-Lipotropin (1-10), porcine, function:

    - **Receptor Binding and Signal Transduction:** In vitro assays demonstrate that Beta-Lipotropin (1-10) binds to specific GPCRs, leading to downstream activation of cAMP and MAPK pathways (Li et al., 2017, Peptides).
    - **Central Nervous System Effects:** Intracerebroventricular administration in rodent models results in altered locomotor activity, modulation of stress-induced behaviors, and changes in pain thresholds (Kastin et al., 1980, Science).
    - **Metabolic Outcomes:** Chronic administration in animal models has been associated with increased lipolysis and reduced adiposity, supporting its role in energy homeostasis (Smith & Funder, 1988, Endocrine Reviews).
    - **Neuroprotection:** In vitro studies using neuronal cultures indicate that Beta-Lipotropin (1-10) can reduce oxidative stress-induced apoptosis, suggesting a neuroprotective effect (Brunton et al., 2012, J Mol Endocrinol).
    - **Pharmacokinetics:** The peptide exhibits rapid plasma clearance but demonstrates significant central effects due to its ability to cross the blood-brain barrier (Kastin et al., 1980, Science).

    These findings collectively underscore the peptide’s potential as a research tool and its translational relevance for metabolic, neuroendocrine, and pain-related disorders.

    Usage Guidelines and Best Practices
    For research applications, Beta-Lipotropin (1-10), porcine, should be handled and administered according to established peptide research protocols:

    - **Preparation:** The peptide is typically supplied as a lyophilized powder. It should be reconstituted in sterile water or appropriate buffer (e.g., phosphate-buffered saline) to the desired concentration. Aliquots should be stored at -20°C to -80°C to maintain stability.
    - **Dosing:** Experimental dosing varies depending on the model system and research objective. In rodent studies, doses ranging from 0.1 to 10 mg/kg have been reported for central and peripheral administration (Li et al., 2017, Peptides).
    - **Route of Administration:** Both central (intracerebroventricular) and peripheral (intraperitoneal, subcutaneous) routes are used. The choice depends on the targeted physiological system and research question.
    - **Controls:** Use of appropriate vehicle controls and, where possible, comparison with full-length beta-lipotropin or other POMC-derived peptides is recommended to delineate specific effects.
    - **Analytical Methods:** Quantification of peptide levels in biological samples can be performed using ELISA, mass spectrometry, or HPLC. Functional assays should include behavioral, metabolic, and molecular endpoints.
    - **Safety:** While the peptide is generally considered safe for laboratory use, standard precautions for handling bioactive peptides should be observed. Institutional guidelines for animal and cell-based research must be followed.

    Future Research Directions
    Despite significant progress, several avenues Additional Resources:
    Related Websites: APExBIO Technology LLC is a premier provider of Small Molecule Inhibitors/Activators, Compound Libraries, Peptides, Assay Kits, Fluorescent Labels, Enzymes, Modified Nucleotides, mRNA synthesis and various tools for Molecular Biology. We carry a broad product line in over 33 different research areas such as cancer, immunology, neurosciences, apoptosis and epigenetics etc. Based in USA (Houston, Texas), we have been serving the needs of customers across the world.
    https://www.apexbt.com/
    Research Article: PMC11567666